Your session is about to expire
← Back to Search
Telehealth Exercise to Music for Huntington's Disease (MtI Trial)
N/A
Recruiting
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Above the age of 21 years
Confirmed diagnosis of a degenerative neurologic disorder such as HD, PD, mild dementia or mild cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if a movement and music exercise program delivered over video chat is feasible and safe for people with neurodegenerative diseases and their caregivers. A secondary goal is to see if the program improves balance, cognition, mobility, and quality of life.
Who is the study for?
This trial is for adults over 21 with neurodegenerative diseases like Huntington's, Parkinson's, or mild cognitive impairments. Participants need a caregiver to assist them, stable medication use, and internet access for the online program. Those already in another trial or doing regular exercise three times a week can't join.
What is being tested?
The study tests if exercising to music through an online telehealth service is doable and safe for people with neurodegenerative diseases and their caregivers. It also looks at whether this improves balance, thinking skills, mobility, and life quality.
What are the potential side effects?
Since the intervention involves physical activity set to music via telehealth services rather than medication or invasive procedures, side effects may include typical exercise-related issues such as muscle soreness or fatigue.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 21 years old.
Select...
I have been diagnosed with a condition like Huntington's, Parkinson's, or mild dementia.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in 12-item Self-Report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 questionnaire from baseline
Change in 12-item Self-Report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 questionnaire from baseline - TELEHEALTH
Change in 4 stage balance test from baseline: feet in tandem from baseline
+16 moreSecondary study objectives
Change in Symbol Digit Modality Test (SDMT) from baseline
Change in Unified Huntington's Disease Rating Scale (UHDRS) Functional Assessment scale from baseline
Change in Unified Huntington's Disease Rating Scale (UHDRS) Independence scale from baseline
+2 moreOther study objectives
Open-ended questionnaire
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Individuals with HDExperimental Treatment1 Intervention
Participants with a confirmed diagnosis of Huntington's disease
Group II: Care PartnersExperimental Treatment1 Intervention
Participants' care partners
Find a Location
Who is running the clinical trial?
Huntington's Disease Society of AmericaUNKNOWN
1 Previous Clinical Trials
15 Total Patients Enrolled
Ohio State UniversityLead Sponsor
866 Previous Clinical Trials
655,064 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 21 years old.I have someone who can help me with my treatment.I can access the internet for an online exercise program.My medications have been the same for the last 4 weeks and will stay the same during the trial.I have been diagnosed with a condition like Huntington's, Parkinson's, or mild dementia.You exercise in a structured program three times a week or more.You regularly help take care of someone who meets the above criteria (for caregivers).
Research Study Groups:
This trial has the following groups:- Group 1: Individuals with HD
- Group 2: Care Partners
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger